Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans
Authors
Keywords
-
Journal
JOURNAL OF ENDOCRINOLOGY
Volume 216, Issue 2, Pages 135-143
Publisher
Bioscientifica
Online
2012-11-06
DOI
10.1530/joe-12-0367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Role of Fibroblast Growth Factor 21 (FGF21) in Undernutrition-Related Attenuation of Growth in Mice
- (2012) Rita Ann Kubicky et al. ENDOCRINOLOGY
- MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
- (2012) Pedro Iglesias et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Fibroblast Growth Factor 21 (FGF21) Inhibits Chondrocyte Function and Growth Hormone Action Directly at the Growth Plate
- (2012) Shufang Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Relationship of Serum Fibroblast Growth Factor 21 with Abnormal Glucose Metabolism and Insulin Resistance: The Baltimore Longitudinal Study of Aging
- (2012) Richard D. Semba et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dynamic Change of Serum FGF21 Levels in Response to Glucose Challenge in Human
- (2012) Zhuofeng Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
- (2012) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
- (2012) Jiayun Shen et al. JOURNAL OF HEPATOLOGY
- FGF21 Takes a Fat Bite
- (2012) C. Canto et al. SCIENCE
- Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease
- (2011) Susan Kralisch et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes: A 5.4-year population-based prospective study in Chinese subjects
- (2011) C. Chen et al. DIABETES CARE
- Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein
- (2011) A Tönjes et al. INTERNATIONAL JOURNAL OF OBESITY
- Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese
- (2011) Zhuofeng Lin et al. PLoS One
- Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
- (2011) Hongmei Yan et al. PLoS One
- Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin
- (2010) Knut Mai et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
- (2010) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Serum fibroblast growth factor–21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis
- (2010) Seung Hyeok Han et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile
- (2010) Zhuofeng Lin et al. PLoS One
- Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany
- (2009) Anke Tönjes et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs
- (2009) Anke Tönjes et al. HUMAN MOLECULAR GENETICS
- Fibroblast Growth Factor-21 May Mediate Growth Hormone Resistance in Anorexia Nervosa
- (2009) Pouneh K. Fazeli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia
- (2009) Sebastian Stein et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
- (2008) Takeshi Inagaki et al. Cell Metabolism
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Serum Levels of the Adipokine FGF21 Depend on Renal Function
- (2008) S. Stein et al. DIABETES CARE
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started